Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Amgen Inc.
Explore Amgen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2021 Revenue
$26.0B
▲ 2.2% vs FY2020 ($25.4B)
Source: Annual report / company filing
Amgen Inc. reported $26.0B in revenue for fiscal year 2021. This represents a growth of 2.2% compared to the 2020 figure of $25.4B. In 2022, revenue increased to $26.3B.
Modest growth as newer drugs offset erosion in legacy products.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $36.8B | — | +10.0% |
| FY2024 | $33.4B | $3.8B | +18.6% |
| FY2023 | $28.2B | — | +7.1% |
| FY2022 | $26.3B | — | +1.3% |
| FY2021 | $26.0B | — | +2.2% |
| FY2020 | $25.4B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.